Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$10,046,290
+$4,157,733 QoQ
Shares Held
39,557
+64.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,108
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banco Santander, S.A. holds $364,857,314 across 11 Drug Manufacturers - General names. JNJ ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
119,853 | $143,755,293 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,088,316 | $62,708,766 | |
| 3 | ABBV |
AbbVie Inc.
|
186,053 | $46,818,375 | |
| 4 | PFE |
Pfizer Inc
|
1,655,686 | $39,868,917 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
266,424 | $33,660,007 | |
| 6 | MRK |
Merck & Co., Inc.
|
117,047 | $15,040,538 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
39,557 | $10,046,290 | |
| 8 | AMGN |
Amgen Inc
|
18,674 | $6,762,228 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,046,290 | 39,557 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,888,557 | 24,090 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $10,726,631 | 51,832 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,709,701 | 52,366 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,345,036 | 54,632 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $9,788,372 | 59,023 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,900,927 | 40,803 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $5,046,383 | 31,139 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,076,214 | 55,256 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $3,995,719 | 25,259 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $8,478,064 | 54,090 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $19,290,883 | 123,858 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $21,020,045 | 126,994 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,731,130 | 120,846 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $26,056,402 | 147,503 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $32,031,300 | 196,078 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $37,606,556 | 211,856 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $45,718,249 | 257,960 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $55,741,789 | 325,842 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $49,244,256 | 304,918 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $51,866,080 | 314,836 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $58,571,216 | 356,381 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $53,740,861 | 341,472 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $47,451,777 | 318,725 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $40,904,202 | 290,864 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $41,096,797 | 313,405 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||